alios Archives - 88Finance

Alios BioPharma Presented Positive Results of Its Anti-RSV Nucleoside Analog AL-8176 in a Phase 2 Challenge Study in Adults Infected With Respiratory Syncytial Virus (RSV) at IDWeek

AL-8176 Treatment Rapidly Achieved Non-Detectability of RSV RNA and Decreased Clinical Symptoms